# US 2003/0228637 A1 · Novel microarrays and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228637 A1
- Document ID: US20030228637A1
- Status: Published application
- Kind: A1
- Application number: 10/280,376
- Filed: 2002-10-24
- Published: 2003-12-11
- Earliest claimed: 2001-04-10
- Assignees: The Trustees of Columbia University in the City of New York
- Inventors: Denong Wang
- Web page: https://patentgrep.com/patent/US20030228637A1

## CPC

- G01N 33/548: Carbohydrates, e.g. dextran
- B01J 19/0046: {Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se C40B50/00)}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- B01J 2219/005: Beads
- B01J 2219/00527: Sheets
- B01J 2219/00605: the compounds being directly bound or immobilised to solid supports
- B01J 2219/00612: the surface being inorganic
- B01J 2219/00617: by chemical means
- B01J 2219/00621: by physical means, e.g. trenches, raised areas
- B01J 2219/00626: Covalent
- B01J 2219/00637: by coating it with another layer
- B01J 2219/00641: the porous medium being continuous, e.g. porous oxide substrates
- B01J 2219/00644: the porous medium being present in discrete locations, e.g. gel pads
- B01J 2219/00725: Peptides
- B01J 2219/00727: Glycopeptides
- B01J 2219/0074: Biological products
- B01L 3/5085: {for multiple samples, e.g. microtitration plates}
- C40B 40/10: Libraries containing peptides or polypeptides, or derivatives thereof
- G01N 2400/00: Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

This invention provides novel nitrocellulose-based or Hydrogel-based microarrays and methods of making and using them (1) to detect the presence of one or more agents in a sample, (2) to determine the amount of one or more agents in a sample, (3) to determine whether a subject is afflicted with a disorder, and (4) to determine whether an agent known to specifically bind to a first compound also specifically binds to a second compound. This invention also provides kits which comprise the instant microarrays. This invention further provides antibodies capable of specifically binding to a glycomer present both on the surface of a mammalian macrophage or intestinal epithelial cell, and on a bacterial cell. Finally, this invention provides diagnostic methods using the instant antibodies.

## Claims

### Claim 1

A microarray comprising a nitrocellulose or Hydrogel support having affixed to its surface at discrete loci a plurality of compounds, wherein (a) at at least one discrete locus is affixed a compound selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody, and (b) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 2 (depends on 1)

The microarray of claim 1, wherein the nitrocellulose or Hydrogel support is selected from the group consisting of a chip, a slide, a filter, and a plate.

### Claim 3

A microarray comprising a plurality of nitrocellulose or Hydrogel or Hydrogel supports, each support having one or a plurality of compounds affixed to its surface at a single discrete locus or a plurality of compounds affixed to its surface at discrete loci, wherein (a) at at least one discrete locus is affixed a compound selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody, and (b) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 4 (depends on 3)

The microarray of claim 3, wherein the nitrocellulose or Hydrogel or Hydrogel support is selected from the group consisting of a chip, a slide, a filter, a plate, and a bead.

### Claim 5 (depends on 1, 3)

The microarray of claim 1 or 3, wherein the number of discrete loci is at least 100.

### Claim 6 (depends on 1, 3)

The microarray of claim 1 or 3, wherein the number of discrete loci is at least 1000.

### Claim 7 (depends on 1, 3)

The microarray of claim 1 or 3, wherein the number of discrete loci is at least 10,000.

### Claim 8 (depends on 1, 3)

The microarray of claim 1 or 3, wherein a glycomer is affixed at at least one locus.

### Claim 9 (depends on 1, 3)

The microarray of claim 1 or 3, wherein an insoluble protein is affixed at at least one locus.

### Claim 10 (depends on 1, 3)

The microarray of claim 1 or 3, wherein a lectin is affixed at at least one locus.

### Claim 11 (depends on 1, 3)

The microarray of claim 1 or 3, wherein an antibody is affixed at at least one locus.

### Claim 12 (depends on 1, 3)

The microarray of claim 1 or 3, wherein at each locus is affixed only one compound.

### Claim 13 (depends on 1, 3)

The microarray of claim 1 or 3, wherein at at least one locus is affixed a plurality of compounds.

### Claim 14 (depends on 1, 3)

The microarray of claim 1 or 3, wherein the microarray has affixed to its surface two or more compounds selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody.

### Claim 15 (depends on 1, 3)

The microarray of claim 1 or 3, wherein the microarray has further affixed to its surface a compound selected from the group consisting of a soluble protein, a nucleic acid and a small molecule.

### Claim 16

An article comprising a nitrocellulose or Hydrogel support having dextran affixed to its surface at discrete loci.

### Claim 17 (depends on 16)

The article of claim 16, wherein the dextran is α(1,6) dextran.

### Claim 18 (depends on 16)

A microarray comprising the article of claim 16, wherein at least one compound is affixed to the dextran at each discrete locus, the composition of compounds at each discrete locus differing from the composition of compounds at at least one other discrete locus.

### Claim 19 (depends on 18)

The microarray of claim 18, wherein the nitrocellulose or Hydrogel support is selected from the group consisting of a chip, a slide, a filter, and a plate.

### Claim 20

An article comprising a plurality of nitrocellulose or Hydrogel supports, each support having dextran affixed to its surface at one or more discrete loci.

### Claim 21 (depends on 20)

The article of claim 20, wherein the dextran is α(1,6) dextran.

### Claim 22 (depends on 20)

A microarray comprising the article of claim 20, wherein at least one compound is affixed to the dextran at each discrete locus, the composition of compounds at each discrete locus differing from the composition of compounds at at least one other discrete locus.

### Claim 23 (depends on 22)

The microarray of claim 22, wherein the nitrocellulose or Hydrogel support is selected from the group consisting of a chip, a slide, a filter, a plate, and a bead.

### Claim 24 (depends on 18, 22)

The microarray of claim 18 or 22, wherein the number of discrete loci is at least 100.

### Claim 25 (depends on 18, 22)

The microarray of claim 18 or 22, wherein the number of discrete loci is at least 1000.

### Claim 26 (depends on 18, 22)

The microarray of claim 18 or 22, wherein the number of discrete loci is at least 10,000.

### Claim 27 (depends on 18, 22)

The microarray of claim 18 or 22, wherein a glycomer is affixed to the dextran at at least one locus.

### Claim 28 (depends on 18, 22)

The microarray of claim 18 or 22, wherein an insoluble protein is affixed to the dextran at at least one locus.

### Claim 29 (depends on 18, 22)

The microarray of claim 18 or 22, wherein a lectin is affixed to the dextran at at least one locus.

### Claim 30 (depends on 18, 22)

The microarray of claim 18 or 22, wherein an antibody is affixed to the dextran at at least one locus.

### Claim 31 (depends on 18, 22)

The microarray of claim 18 or 22, wherein at each locus is affixed only one compound.

### Claim 32 (depends on 18, 22)

The microarray of claim 18 or 22, wherein at at least one locus is affixed a plurality of compounds.

### Claim 33 (depends on 18, 22)

The microarray of claim 18 or 22, wherein the microarray has affixed to the dextran two or more compounds selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody.

### Claim 34 (depends on 18, 22)

The microarray of claim 18 or 22, wherein the microarray has affixed to its surface a compound selected from the group consisting of a soluble protein, a nucleic acid and a small molecule.

### Claim 35 (depends on 1, 3)

A method of detecting in a sample the presence of one or more agents which specifically bind to one or more known glycomers, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known glycomer is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding glycomer in the microarray; and
(b) determining whether any known glycomer in the microarray has an agent specifically bound thereto,
thereby detecting the presence of the one or more agents in the sample.

### Claim 36 (depends on 35)

The method of claim 35, wherein the agent is an antibody which correlates with an inflammatory disease.

### Claim 37 (depends on 35)

The method of claim 35, wherein the agent is an antibody which correlates with an infection.

### Claim 38 (depends on 35)

The method of claim 35, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 39 (depends on 35)

The method of claim 35, wherein the method comprises detecting the presence of a plurality of agents in the sample, each of which binds to a plurality of glycomers.

### Claim 40 (depends on 35)

The method of claim 35, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one glycomer.

### Claim 41 (depends on 1, 3)

A method of detecting in a sample the presence of one or more agents which specifically bind to one or more known insoluble proteins, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known insoluble protein is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding insoluble protein in the microarray; and
(b) determining whether any known insoluble protein in the microarray has an agent specifically bound thereto,
thereby detecting the presence of the one or more agents in the sample.

### Claim 42 (depends on 41)

The method of claim 41, wherein the agent is an antibody which correlates with a disease.

### Claim 43 (depends on 41)

The method of claim 41, wherein the agent is an antibody which correlates with an infection.

### Claim 44 (depends on 41)

The method of claim 41, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 45 (depends on 41)

The method of claim 41, wherein the method comprises detecting the presence of a plurality of agents in the sample, each of which binds to a plurality of insoluble proteins.

### Claim 46 (depends on 41)

The method of claim 41, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one insoluble protein.

### Claim 47 (depends on 1, 3)

A method of detecting in a sample the presence of one or more agents which specifically bind to one or more known antibodies or lectins, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known antibody or lectin is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding antibody or lectin in the microarray; and
(b) determining whether any known antibody or lectin in the microarray has an agent specifically bound thereto,
thereby detecting the presence of the one or more agents in the sample.

### Claim 48 (depends on 47)

The method of claim 47, wherein the agent is an antibody which correlates with a disease.

### Claim 49 (depends on 47)

The method of claim 47, wherein the agent is an antibody which corresponds to an infection.

### Claim 50 (depends on 47)

The method of claim 47, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 51 (depends on 47)

The method of claim 47, wherein the method comprises detecting the presence of a plurality of agents in the sample, each of which binds to a plurality of lectins or antibodies.

### Claim 52 (depends on 47)

The method of claim 47, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one lectin or antibody.

### Claim 53 (depends on 1, 3)

A method of determining the amount of one or more agents in a sample, each of which specifically binds to one or more known glycomers, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known glycomer is affixed at at least one discrete locus, and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding glycomer in the microarray;
(b) for each known glycomer in the microarray, determining the amount of agent specifically bound thereto; and
(c) comparing the amounts so determined to a known standard,
thereby determining the amount of the one or more agents in the sample.

### Claim 54 (depends on 53)

The method of claim 53, wherein the agent is an antibody which correlates with an inflammatory disease.

### Claim 55 (depends on 53)

The method of claim 53, wherein the agent is an antibody which correlates with an infection.

### Claim 56 (depends on 53)

The method of claim 53, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 57 (depends on 53)

The method of claim 53, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to a plurality of glycomers.

### Claim 58 (depends on 53)

The method of claim 53, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one glycomer.

### Claim 59 (depends on 1, 3)

A method of determining the amount of one or more agents in a sample, each of which specifically binds to one or more known insoluble proteins, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known insoluble protein is affixed at at least one discrete locus, and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding insoluble protein in the microarray;
(b) for each known insoluble protein in the microarray, determining the amount of agent specifically bound thereto; and
(c) comparing the amounts so determined to a known standard,
thereby determining the amount of the one or more agents in the sample.

### Claim 60 (depends on 59)

The method of claim 59, wherein the agent is an antibody which correlates with an inflammatory disease.

### Claim 61 (depends on 59)

The method of claim 59, wherein the agent is an antibody which correlates with an infection.

### Claim 62 (depends on 59)

The method of claim 59, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 63 (depends on 59)

The method of claim 59, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to a plurality of insoluble proteins.

### Claim 64 (depends on 59)

The method of claim 59, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one insoluble protein.

### Claim 65 (depends on 1, 3)

A method of determining the amount of one or more agents in a sample, each of which specifically binds to one or more known antibodies or lectins, which method comprises:
(a) contacting the sample with the microarray of claim 1 or 3, wherein each known antibody or lectin is affixed at at least one discrete locus, and wherein the contacting is performed under conditions which would permit an agent, if present in the sample, to specifically bind to its corresponding antibody or lectin in the microarray;
(b) for each known antibody or lectin in the microarray, determining the amount of agent specifically bound thereto; and
(c) comparing the amounts so determined to a known standard,
thereby determining the amount of the one or more agents in the sample.

### Claim 66 (depends on 65)

The method of claim 65, wherein the agent is an antibody which correlates with an inflammatory disease.

### Claim 67 (depends on 65)

The method of claim 65, wherein the agent is an antibody which correlates with an infection.

### Claim 68 (depends on 65)

The method of claim 65, wherein the agent is an antibody which correlates with the presence of a tumor.

### Claim 69 (depends on 65)

The method of claim 65, which method comprises determining the amount of a plurality of agents in the sample, each of which binds to a plurality of lectins or antibodies.

### Claim 70 (depends on 65)

The method of claim 65, wherein the method comprises determining the amount of a plurality of agents in the sample, each of which binds to one lectin or antibody.

### Claim 71 (depends on 1, 3)

A method of determining whether a subject is afflicted with a disorder characterized by the presence or absence in an afflicted subject of an agent which specifically binds to a known glycomer, which method comprises:
(a) contacting a suitable sample from the subject with the microarray of claim 1 or 3, wherein the known glycomer is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit the agent, if present in the sample, to specifically bind to the known glycomer in the microarray; and
(b) determining whether the known glycomer in the microarray has the agent specifically bound thereto,
thereby determining whether the subject is afflicted with the disorder.

### Claim 72 (depends on 71)

The method of claim 71, wherein the subject is human.

### Claim 73 (depends on 71)

The method of claim 71, wherein the disorder is an inflammatory disorder.

### Claim 74 (depends on 73)

The method of claim 73, wherein the inflammatory disorder is celiac disease.

### Claim 75 (depends on 1, 3)

A method of determining whether a subject is afflicted with a disorder characterized by the presence or absence in an afflicted subject of an agent which specifically binds to a known insoluble protein, which method comprises:
(a) contacting a suitable sample from the subject with the microarray of claim 1 or 3, wherein the known insoluble protein is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit the agent, if present in the sample, to specifically bind to the known insoluble protein in the microarray; and
(b) determining whether the known insoluble protein in the microarray has the agent specifically bound thereto,
thereby determining whether the subject is afflicted with the disorder.

### Claim 76 (depends on 75)

The method of claim 75, wherein the subject is human.

### Claim 77 (depends on 1, 3)

A method of determining whether a subject is afflicted with a disorder characterized by the presence or absence in an afflicted subject of an agent which specifically binds to a known antibody or lectin, which method comprises:
(a) contacting a suitable sample from the subject with the microarray of claim 1 or 3, wherein the known antibody or lectin is affixed at at least one discrete locus and wherein the contacting is performed under conditions which would permit the agent, if present in the sample, to specifically bind to the known antibody or lectin in the microarray; and
(b) determining whether the known antibody or lectin in the microarray has the agent specifically bound thereto,
thereby determining whether the subject is afflicted with the disorder.

### Claim 78 (depends on 77)

The method of claim 77, wherein the subject is human.

### Claim 79 (depends on 77)

The method of claim 77, wherein the disorder is HIV-1 infection.

### Claim 80 (depends on 1, 3)

A method of determining whether an antibody known to specifically bind to a first glycomer also specifically binds to a second glycomer, which method comprises:
(a) contacting the antibody with the microarray of claim 1 or 3, wherein a plurality of glycomers, other than the first glycomer, are affixed at discrete loci in the microarray, and wherein the contacting is performed under conditions which would permit the antibody to specifically bind to the first glycomer if it were present in the microarray; and
(b) determining whether any of the glycomers in the microarray, other than the first glycomer, has the antibody specifically bound thereto,
thereby determining whether the antibody also specifically binds to a second glycomer.

### Claim 81 (depends on 1, 3)

A method of determining whether an antibody known to specifically bind to a first insoluble protein also specifically binds to a second insoluble protein, which method comprises:
(a) contacting the antibody with the microarray of claim 1 or 3, wherein a plurality of insoluble proteins, other than the first insoluble protein, are affixed at discrete loci in the microarray, and wherein the contacting is performed under conditions which would permit the antibody to specifically bind to the first insoluble protein if it were present in the microarray; and
(b) determining whether any of the insoluble proteins in the microarray, other than the first insoluble protein, has the antibody specifically bound thereto,
thereby determining whether the antibody also specifically binds to a second insoluble protein.

### Claim 82

A method of making a microarray comprising a nitrocellulose or Hydrogel support having affixed to its surface at discrete loci a plurality of compounds, which method comprises contacting the nitrocellulose or Hydrogel support with the compounds under suitable conditions, whereby (a) at at least one discrete locus is affixed a compound selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody, and (b) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 83

A method of making a microarray comprising a plurality of nitrocellulose or Hydrogel supports, each support having one or a plurality of compounds affixed to its surface at a single discrete locus or a plurality of compounds affixed to its surface at discrete loci, which method comprises contacting the nitrocellulose or Hydrogel supports with the compounds under suitable conditions, whereby (a) at at least one discrete locus is affixed a compound selected from the group consisting of a glycomer, an insoluble protein, a lectin and an antibody, and (b) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 84 (depends on 16)

A method of making the article of claim 16 comprising contacting a nitrocellulose or Hydrogel support with dextran at discrete loci under suitable conditions.

### Claim 85 (depends on 84)

The method of claim 84, further comprising the step of affixing at least one compound to the dextran at each discrete locus, whereby the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 86 (depends on 20)

A method of making the article of claim 20 comprising contacting a plurality of nitrocellulose or Hydrogel supports with dextran, whereby each support has dextran affixed to its surface at one or more discrete loci.

### Claim 87 (depends on 86)

The method of claim 86, further comprising the step of affixing at least one compound to the dextran at each discrete locus, whereby the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus.

### Claim 88 (depends on 1, 3, 18, 22)

A kit comprising the microarray of claim 1, 3, 18 or 22 and instructions for use.

### Claim 89 (depends on 1, 3, 18, 22)

A kit comprising the microarray of claim 1, 3, 18 or 22 and a desiccant.

### Claim 90 (depends on 1, 3, 18, 22)

A kit comprising the microarray of claim 1, 3, 18 or 22 immersed in an aqueous solution.

### Claim 91 (depends on 71)

A kit for practicing the method of claim 71, which comprises:
(a) a microarray comprising a nitrocellulose or Hydrogel support having affixed to its surface at discrete loci a plurality of compounds, wherein (i) at at least one discrete locus is affixed the glycomer to which the agent present or absent in an afflicted subject specifically binds, and (ii) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus; and
(b) instructions for use.

### Claim 92 (depends on 75)

A kit for practicing the method of claim 75, which comprises:
(a) a microarray comprising a nitrocellulose or Hydrogel support having affixed to its surface at discrete loci a plurality of compounds, wherein (i) at at least one discrete locus is affixed the insoluble protein to which the agent present or absent in an afflicted subject specifically binds, and (ii) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus; and
(b) instructions for use.

### Claim 93 (depends on 77)

A kit for practicing the method of claim 77, which comprises:
(a) a microarray comprising a nitrocellulose or Hydrogel support having affixed to its surface at discrete loci a plurality of compounds, wherein (i) at at least one discrete locus is affixed the antibody or lectin to which the agent present or absent in an afflicted subject specifically binds, and (ii) the composition of compounds at each discrete locus differs from the composition of compounds at at least one other discrete locus; and
(b) instructions for use.

### Claim 94

An antibody capable of specifically binding to a glycomer present on the surface of a mammalian macrophage, which glycomer, or structural mimic thereof, is also endogenous to, and present on the surface of, a bacterial cell.

### Claim 95 (depends on 94)

The antibody of claim 94, wherein the antibody is a groove-type antibody.

### Claim 96 (depends on 94)

The antibody of claim 94, wherein the antibody is designated 4.3.F1 (ATCC Accession No. PTA-3259).

### Claim 97 (depends on 94)

The antibody of claim 94, wherein the antibody is designated 45.21.1 (ATCC Accession No. PTA-3260).

### Claim 98

An antibody capable of specifically binding to a glycomer present on the surface of a mammalian intestinal epithelial cell, which glycomer, or structural mimic thereof, is also endogenous to, and present on the surface of, a bacterial cell.

### Claim 99 (depends on 98)

The antibody of claim 98, wherein the antibody is a cavity-type antibody.

### Claim 100 (depends on 98)

The antibody of claim 98, wherein the antibody is designated 16.4.12E (ATCC Accession No. PTA-3261).

### Claim 101 (depends on 94)

A method of determining whether a subject is afflicted with a disorder characterized by the presence of a glycomer on the surface of macrophages in an afflicted subject, which glycomer, or structural mimic thereof, is also endogenous to, and present on the surface of, a bacterial cell, comprising:
(a) contacting a sample of the subject's macrophages with the antibody of claim 94; and
(b) determining whether the antibody specifically binds to the macrophages in the sample,
such binding indicating that the subject is afflicted with the disorder.

### Claim 102 (depends on 101)

The method of claim 101, wherein the subject is human.

### Claim 103 (depends on 101)

The method of claim 101, wherein the disorder is an immune disorder or an inflammatory disorder.

### Claim 104 (depends on 98)

A method of determining whether a subject is afflicted with a disorder characterized by the presence of a glycomer on the surface of intestinal epithelial cells in an afflicted subject, which glycomer, or structural mimic thereof, is also endogenous to, and present on the surface of, a bacterial cell, comprising:
(a) contacting a sample of the subject's intestinal epithelial cells with the antibody of claim 98; and
(b) determining whether the antibody specifically binds to the intestinal epithelial cells in the sample,
such binding indicating that the subject is afflicted with the disorder.

### Claim 105 (depends on 104)

The method of claim 104, wherein the subject is human.

### Claim 106 (depends on 104)

The method of claim 104, wherein the disorder is an immune disorder or an inflammatory disorder.

### Claim 107 (depends on 106)

The method of claim 106, wherein the disorder is celiac disease.
